Conavi Medical Corp.
CNVIF
$0.33
$0.000.61%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 122.64% | 33.06% | 54.62% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 122.64% | 33.06% | 54.62% | -- | -- |
| Cost of Revenue | -68.83% | -52.77% | -20.86% | -- | -- |
| Gross Profit | 48,020.97% | 177.16% | 158.33% | -- | -- |
| SG&A Expenses | -17.16% | -13.51% | 12.15% | -- | -- |
| Depreciation & Amortization | -19.27% | -21.35% | -25.91% | -- | -- |
| Other Operating Expenses | -32.60% | -35.86% | -35.86% | -- | -- |
| Total Operating Expenses | -23.93% | -22.48% | 2.87% | -- | -- |
| Operating Income | 35.53% | 30.13% | 4.41% | -- | -- |
| Income Before Tax | 58.29% | 20.52% | -32.97% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.29% | 20.52% | -32.97% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.29% | 20.52% | -32.97% | -- | -- |
| EBIT | 35.53% | 30.13% | 4.41% | -- | -- |
| EBITDA | 35.78% | 29.95% | 3.15% | -- | -- |
| EPS Basic | 95.43% | 49.40% | -8.49% | -- | -- |
| Normalized Basic EPS | 91.91% | 63.59% | 23.21% | -- | -- |
| EPS Diluted | 95.43% | 49.40% | -8.49% | -- | -- |
| Normalized Diluted EPS | 91.91% | 63.59% | 23.21% | -- | -- |
| Average Basic Shares Outstanding | 842.12% | 554.12% | 300.91% | -- | -- |
| Average Diluted Shares Outstanding | 842.12% | 554.12% | 300.91% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |